RT Journal Article
T1 Management of patients with hidradenitis suppurativa during the COVID-19 pandemic.
A1 Montero-Vilchez, Trinidad
A1 Martinez-Lopez, Antonio
A1 Salvador-Rodriguez, Luis
A1 Molina-Leyva, Alejandro
A1 Arias-Santiago, Salvador
K1 Hidradenitis Suppurativa
K1 Aged
K1 Cardiovascular Diseases
K1 Pandemics
K1 Death
K1 Obesity
AB The recent coronavirus disease 2019 (COVID-19) pandemic, caused by the Severe acute respiratory syndrome-associated coronavirus type 2 (SARS-CoV-2) virus, has spread all over the world. As of April 21, 2020, there were 2 478 948 cases of infection, of which 652 046 have resolved, and 170 399 people have died in 185 different countries. The elderly and people with underlying conditions such as cardiovascular disease, obesity, diabetes or cancer are at the highest risk of infection and prone to serious outcomes.
PB Hindawi Limited
YR 2020
FD 2020-06-17
LK http://hdl.handle.net/10668/15769
UL http://hdl.handle.net/10668/15769
LA en
NO Montero-Vilchez T, Martinez-Lopez A, Salvador-Rodriguez L, Molina-Leyva A, Arias-Santiago S. Management of patients with hidradenitis suppurativa during the COVID-19 pandemic. Dermatol Ther. 2020 Nov;33(6):e13875.
DS RISalud
RD Oct 14, 2025